Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
Do you use CNS dosing of antibiotics for any portion of the treatment course in patients with infective endocarditis who have cerebral emboli?
Related Questions
Do you use metronidazole twice daily dosing for routine anaerobic coverage such as non-CNS, H. pylori, C. diff, or parasitic infections?
Do you routinely test for co-infection of other tick-borne illnesses in a patient who tests positive for Lyme, anaplasmosis, babesiosis, or ehrlichiosis?
How have the results of the BALANCE trial, which demonstrated the noninferiority of 7 days of antibiotics compared to 14 days for non-S. aureus bloodstream infections, influenced your practice?
Is arbovirus testing available in your state outside the traditional summer season?
Do you routinely transition to PO antibiotics for patients with native joint septic arthritis whom have undergone washout and the organism is not S. aureus?
Do you recommend using topical metronidazole for managing odor related to pressure ulcers?
How long would you wait to place a new bone flap for a patient with C. auris skull osteomyelitis associated with cranioplasty s/p bone flap removal, who is currently on anti-fungal therapy?
What is the recommended duration of therapy for Enterococcal bacteremia from a urinary source in patients with prosthetic valves assuming negative TEE and clearance of bacteremia?
When should antibiotics be discontinued for an immunocompetent patient with signs of meningoencephalitis who undergoes an LP without prior administration of antibiotics and the CSF shows a neutrophilic pleocytosis, negative Gram stain, negative PCR Panel, and negative CSF culture at day 3-5?
Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?
